3016Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension. (28th August 2018) - Galie, N; Gaine, S; Channick, R; Ghofrani, H A; Hoeper, M; Lang, I; McLaughlin, V; Preiss, R; Rubin, L; Shiraga, Y; Simonneau, G; Sitbon, O; et al.